Efficacy and Safety of a Citrate-based Anticoagulation With Calcium-free Phosphate-containing Fluid in Renal Replacement Therapy
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Dec 30, 2019
Trial Information
Current as of May 10, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Acute renal failure requiring CRRT
- • 2. Suitability for regional anticoagulation of the CRRT circuit
- • 3. Clinical equipoise regarding the method of circuit anticoagulation
- • 4. Subject is affiliated with a social security system (if required by individual country regulations).
- • 5. Subject meets national regulatory criteria for clinical trial participation.
- • 6. Subject or subject's Legally Authorized Representative (LAR) has signed the study Informed Consent form
- Exclusion Criteria:
- • 1. Age less than 18 years
- • 2. Expected stay in ICU less than 24 hours
- • 3. Pregnant or breastfeeding
- • 4. Suspected ischemic hepatitis or liver failure
- • 5. Chronic kidney disease requiring dialysis prior to ICU admission
- • 6. As applicable by French law, subject who is a protected individual such as an incompetent adult or incarcerated person
- • 7. Metformin and acethaminophen intoxication
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Emilie GARRIDO
Study Director
Assistance Publique Hopitaux De Marseille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials